In this work we have identified a new role for miR-150 in promoting myeloid differentiation of AML cell lines, CD34+ progenitor cells from healthy individuals, and primary BC CML and AML patient cells. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.